` Comparison: HYFT vs 603259 - Alpha Spread

HYFT
vs
603259

Over the past 12 months, HYFT has outperformed WuXi AppTec Co Ltd, delivering a return of +134% compared to the WuXi AppTec Co Ltd's +99% growth.

Start AI Comparison

Smart Verdict
AI-Powered

Not Sure Which Stock Wins?
Let AI Decide.
HYFT
603259
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Smart Verdict is Ready!
See Who Stands Out.
All the numbers, charts, and metrics summarized into one smart verdict.
Stocks Compared:
Show Comparison Results
Summarizing...
We need a little more time to summarize the results

Valuation Comparison

HYFT Intrinsic Value
1.1 USD
Undervaluation 2%
Intrinsic Value
Price $1.07
Intrinsic Value
102.33 CNY
Overvaluation 3%
Intrinsic Value
Price ¥105.52
Company Last Price Intrinsic Value DCF Value Multiples-Based Value Wall St Target
Immunoprecise Antibodies Ltd
NASDAQ:HYFT
1.07 USD
WuXi AppTec Co Ltd
SSE:603259
105.52 CNY
No Stocks Selected

Compare the stock's valuation with its competitors.

Select Stocks to Compare
Valuation Scenario:
Bear Case
Base Case
Bull Case

Growth Comparison

Growth Over Time
HYFT, 603259

HYFT
603259
Add Stock
Revenue
www.alphaspread.com
No Stocks Selected

Compare company's financials with its competitors.

Select Stocks to Compare
Company LTM Historical Growth Growth Streak % Positive Years Max Drawdown Volatility Forecasted Growth
3 Years 5 Years 10 Years 1 Year 3 Years
Immunoprecise Antibodies Ltd
Revenue
WuXi AppTec Co Ltd
Revenue

All metrics are calculated based on data from the last 10 years.

No Stocks Selected

Compare company's financials with its competitors.

Select Stocks to Compare

Profitability Comparison

Free Cash Flow
HYFT, 603259

HYFT
603259
Add Stock
Free Cash Flow
www.alphaspread.com
No Stocks Selected

Compare company's free cash flow with its competitors.

Select Stocks to Compare
Company LTM Average Historical Growth FCF Margin Conversion
3 Years 5 Years 3 Years 5 Years 10 Years
Immunoprecise Antibodies Ltd
NASDAQ:HYFT
WuXi AppTec Co Ltd
SSE:603259
No Stocks Selected

Compare company's free cash flow with its competitors.

Select Stocks to Compare
What is Free Cash Flow?

Gross Margin

HYFT
60.3%
WuXi AppTec Co Ltd
47.5%

Operating Margin

HYFT
-65.6%
WuXi AppTec Co Ltd
35.9%

Net Margin

HYFT
-66.5%
WuXi AppTec Co Ltd
42.1%

FCF Margin

HYFT
-64.8%
WuXi AppTec Co Ltd
25.7%

ROE

HYFT
-61.2%
WuXi AppTec Co Ltd
27.7%

ROA

HYFT
-35.7%
WuXi AppTec Co Ltd
20.9%

ROIC

HYFT
-72.4%
WuXi AppTec Co Ltd
22.6%

ROCE

HYFT
-44.3%
WuXi AppTec Co Ltd
22%

Solvency Comparison

No Stocks Selected

Compare company's equity waterfall with its competitors.

Select Stocks to Compare
Balance Sheet Comparison
No Stocks Selected

Compare company's balance sheet with its competitors.

Select Stocks to Compare

Stocks Performance

Stocks Performance
HYFT, 603259

Loading
HYFT
603259
Add Stock
www.alphaspread.com
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
HYFT, 603259

Loading
HYFT
603259
Difference
www.alphaspread.com

Performance By Year
HYFT, 603259

Loading
HYFT
603259
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Not Sure Which Stock Wins?
Let AI Decide
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Compare HYFT to other stocks
0KHE
PerkinElmer Inc
P
More expensive
vs HYFT
TMO
Thermo Fisher Scientific Inc
More expensive
vs HYFT
DHR
Danaher Corp
More expensive
vs HYFT
207940
Samsung Biologics Co Ltd
More expensive
vs HYFT
Unlock Full Access to Alpha Spread
Create Free Account
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett